|
| Press Releases |
|
 |
|
| Saturday, August 31, 2013 |
|
|
NANOBIOTIX: Half Year Results for the Period Ended 30 June 2013 |
| NANOBIOTIX (the "Company") (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, has published today its half year results for the six month period ended 30 June 2013 (HY1). more info >> |
|
| Thursday, July 4, 2013 |
|
|
Nanobiotix Announces EUR 2.8 Million Grant from bpifrance to Accelerate Development of NBTXR3 in a Third New Indication |
| NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today it has secured c.EUR 9 million in funding from bpifrance (formerly OSEO) of which EUR 2.8 million is directly attributable to the Company. more info >> |
|
| Wednesday, June 26, 2013 |
|
|
Nanobiotix Announces the Selection of its Second NanoXray Product, NBTX-IV and a Collaboration with the National Cancer Institute for Development |
| NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces the selection of a new product for development, NBTX-IV. more info >> |
|
| Thursday, June 13, 2013 |
|
|
Nanobiotix Receives Approval from ANSM to Start New Clinical Trial with Lead Product NBTXR3 |
| NANOBIOTIX (Euronext: NANO) announces today that its lead compound NBTXR3 has received authorization from the French Medicine Agency, ANSM, to start a clinical trial in patients with locally advanced cancers of the oral cavity or oropharynx (head and neck cancer), at the Institut Curie, Paris, France, a French leading cancer treatment center. more info >> |
|
| Monday, June 3, 2013 |
|
|
Nanobiotix's NBTXR3 Achieves Clinical Milestone Reaching Proof-Of-Concept in Phase I Trial of Soft Tissue Sarcoma |
| NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces positive Phase I interim results of its lead nanoparticle-based product, NBTXR3, in patients with Soft Tissue Sarcoma (STS). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
The USPA and U.S. Polo Assn. Celebrate 135th Anniversary with Global Sport and Fashion Events and Launch of "Born to Play"
Jan 30, 2025 20:00 HKT/SGT
|
|
|
Mazda Production and Sales Results for December 2024 and for January through December 2024
Jan 30, 2025 16:44 JST
|
|
|
Honda、2024年12月度 四輪車 生産・販売・輸出実績を発表
Jan 30, 2025 15:00: JST
|
|
|
トヨタ、2024年 年間（1月－12月）販売・生産・輸出実績を発表
Jan 30, 2025 15:00: JST
|
|
|
Lexus Announces Global Sales Results for 2024
Jan 30, 2025 15:52 JST
|
|
|
三菱重工サーマルシステムズ、2024年度省エネ大賞で「資源エネルギー庁長官賞」を受賞
Jan 30, 2025 14:00: JST
|
|
|
MHI Thermal Systems Receives 2024 Agency for Natural Resources and Energy Commissioner's Award from ECCJ for TEJ35AM Electric-Driven Transport Refrigeration Unit Integrated with Isuzu's ELF EV
Jan 30, 2025 14:13 JST
|
|
|
三菱造船、インドネシア海上保安機構向けの巡視船を受注
Jan 30, 2025 12:00: JST
|
|
|
富士通、スペイン大手の労働災害・疾病相互保険会社ASEPEYO様の保険給付に関わるシステムのモダナイゼーションを支援
Jan 30, 2025 12:00: JST
|
|
|
Mitsubishi Shipbuilding Receives Order for an Offshore Patrol Vessel from the Indonesian Maritime Security Agency
Jan 30, 2025 12:35 JST
|
|
|
Fujitsu and Asepeyo collaborate to modernise the management of occupational benefits and contingencies
Jan 30, 2025 11:56 JST
|
|
|
Fourth Star Launches Immersive Media Streaming Platform
Jan 30, 2025 10:30 HKT/SGT
|
|
|
Suzuki, Daihatsu, and Toyota Decide on the Release Schedule for Mini-Commercial Van Electric Vehicles
Jan 30, 2025 10:56 JST
|
|
|
Supply Chain Specialists OMP Strengthen Leadership to Support Strategic Growth
Jan 30, 2025 09:48 HKT/SGT
|
|
|
A Quantum Leap into Uplisting: Spectral Capital and the Next Generation of Computing
Jan 29, 2025 22:47 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
